2019
Prioritization of Patient-Reported Outcomes by Women With Metastatic Breast Cancer
Mougalian SS, Aminawung JA, Presley CJ, Canavan ME, Holland ML, Hu X, Gross CP. Prioritization of Patient-Reported Outcomes by Women With Metastatic Breast Cancer. JCO Clinical Cancer Informatics 2019, 3: 1-3. PMID: 30730764, DOI: 10.1200/cci.18.00107.Peer-Reviewed Original Research
2008
Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes
Holland ML, Huston A, Noyes K. Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes. Value In Health 2008, 12: 207-216. PMID: 18647256, DOI: 10.1111/j.1524-4733.2008.00418.x.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAlgorithmsBreast NeoplasmsCost-Benefit AnalysisFemaleGenes, BRCA1Genes, BRCA2Genetic Predisposition to DiseaseGenetic TestingHealth Care CostsHumansIncidenceLife ExpectancyMarkov ChainsMastectomyMiddle AgedModels, EconomicMonte Carlo MethodMutationOvarian NeoplasmsOvariectomyPatient SatisfactionQuality-Adjusted Life YearsRisk FactorsUnited StatesConceptsQuality-adjusted life years